1. Home
  2. RMBI vs CUE Comparison

RMBI vs CUE Comparison

Compare RMBI & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Richmond Mutual Bancorporation Inc.

RMBI

Richmond Mutual Bancorporation Inc.

N/A

Current Price

$15.94

Market Cap

248.0M

Sector

Finance

ML Signal

N/A

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

N/A

Current Price

$26.79

Market Cap

233.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RMBI
CUE
Founded
1887
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
248.0M
233.5M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
RMBI
CUE
Price
$15.94
$26.79
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$120.00
AVG Volume (30 Days)
40.7K
176.4K
Earning Date
04-23-2026
05-13-2026
Dividend Yield
3.85%
N/A
EPS Growth
27.17
61.11
EPS
0.51
N/A
Revenue
N/A
$27,466,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.18
N/A
Revenue Growth
N/A
195.75
52 Week Low
$12.77
$0.17
52 Week High
$16.59
$45.50

Technical Indicators

Market Signals
Indicator
RMBI
CUE
Relative Strength Index (RSI) 54.05 48.41
Support Level $15.75 $24.35
Resistance Level $16.17 $33.95
Average True Range (ATR) 0.25 3.34
MACD -0.04 0.13
Stochastic Oscillator 45.69 38.18

Price Performance

Historical Comparison
RMBI
CUE

About RMBI Richmond Mutual Bancorporation Inc.

Richmond Mutual Bancorp Inc is a bank holding company. Along with its subsidiary, it is mainly engaged in attracting deposits from the general public, as well as brokered deposits, and investing those funds in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one- to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. It also obtains funds by utilizing Federal Home Loan Bank (FHLB) advances. These funds are generally invested in investment securities, including mortgage-backed and mortgage-related securities and agency and municipal bonds. The Group's primary market area includes Wayne and Shelby counties in Indiana and Shelby, Miami, and Franklin counties in Ohio.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.

Share on Social Networks: